Hillary’s resume is better than yours.
1. Hillary Clinton Joins LinkedIn
The News: Presidential hopeful Hillary Clinton has joined LinkedIn. Her summary section is obviously pretty impressive:
Wife, mother, grandmother, women and kids advocate, FLOTUS, FLOAR, Senator, Secretary of State, dog person, hair icon, pantsuit aficionado, 2016 presidential candidate.
(Weirdly, President Barack Obama joined Twitter
just a few days ago. Coincidence?)
Read more »
1. Just Days after Abington and Jefferson Merger, Aria Health Exploring a Deal
The News: Aria Health is the latest health system to explore a merger deal. Although the company says there is no deal or potential partner is in place, it would certainly be an attractive partner considering its three hospitals in Northeast Philadelphia. Aria hopes to make a decision by late summer.
Read more »
Psychiatrist Julie Holland wrote in the New York Times this weekend about adjudicating the female mood, which ever since the publication of the feminist classic The Yellow Wallpaper, a book chronicling the imprisonment of a “hysterical” woman, has been the subject of peculiar debate. When a woman is moody, does it mean she’s crazy? Or is she simply experiencing hormonal or emotional differences that serve her evolutionary purpose?
Thankfully, as of 2015, we’ve come to a consensus closer to the latter point of view, at least scientifically. This is chronicled in Holland’s cheekily titled book, Moody Bitches: The Truth About the Drugs You’re Taking, the Sleep You’re Missing, the Sex You’re Not Having, and What’s Really Making You Crazy.
But colloquially and in everyday life, the “psycho” bitch who won’t stop calling after a breakup, the crazy girlfriend who’s super jealous, the chick who’s a nightmare when she’s PMS-ing — these tropes are all too common. Read more »
Philadelphia is all atwitter currently with news out of Temple University that researchers there have gotten a step closer to a so-called cure for HIV. Basically, medical researchers are doing their jobs. Being medical researchers, though, they need to gin up some interest and rationale for more funding, so they’ve decided to recklessly issue a statement so slippery you can’t exactly disagree with it: “This is one important step,” says Temple’s Dr. Kamel Khalili, “on the path toward a permanent cure for AIDS.”
Thanks to those four little letters — “cure” — many journalists who have no experience or strong understanding about HIV/AIDS are writing about HIV/AIDS and society is yet again unfurling the “MISSION ACCOMPLISHED” banner. HIV/AIDS is about to be over! Will the last the person out please shut off the lights? Thanks.
Most people are zooming by the fact that this Temple discovery has no relevance to people living today or even in the near future; the discovery is simply a “proof of concept” with a completely uncertain future use, particularly if it’s anything like past “steps on the path toward a permanent cure for AIDS.” More on that later.
Read more »
The Rittenhouse Women’s Wellness Center has been taking care of the medical needs of Center City women — and exclusively women — since its opening at 1632 Pine Street in 2008. Most of the women who went there loved it. And what’s not for a woman to love? An all-female staff. Same-day sick appointments. Quick callbacks from the doctors. But last week, the practice instituted a policy that has some women furious. Read more »
The news was enough to make a testosterone induced manly man shrivel.
It was late last year that JAMA, the Journal of the American Medical Association, published the results of research that claimed that men who use testosterone supplementation have a 29 percent greater chance of dying from a heart attack or stroke within three years of use.
Until the study, testosterone was the hottest medical product on the market. You couldn’t listen to talk radio or watch a sporting event without being asked if you had “low-T” during the commercial break. That would explain why you were sitting on your couch instead of playing basketball, having sex and generally enjoying your life. The announcer then promised that a gel, a pill, or an injection would transform you from a disinterested lump of flesh into a man again.
Now those ads have been replaced new ones from law firms looking to sign up clients for class action lawsuits. Read more »
Two recent news stories have brought an important question into the public dialogue: How much power do parents have over the lives — and deaths — of their children?
Read more »
Tom Corbett, in a final effort to push his alternative to the Affordable Care Act’s Medicaid expansion, will now ask the Obama administration to formally approve it. It would function similarly to the current Medicaid expansion–which 25 states, including all of PA’s neighbors have agreed to–which offers Medicaid to all those living within 133% of the poverty line. Except for a couple thorny factors.
Read more »
In November, the men of the Today show stopped shaving to raise awareness for men’s health, specifically testicular and prostate cancer. November is a key ratings month in television and the Beards for Better Balls stunt was attention-getting for a good cause.
But when a couple of the Today men decided to get their prostates checked live on the show. Well, pardon the pun, but they scraped bottom. It was inaccurate, unethical and dangerous. All of which I found out from my doctor when I went in for a physical the other day. He wanted to talk more about Matt Lauer and Al Roker’s prostates than mine.
“I watched it live,” my doctor told me, “and couldn’t believe they were pushing the PSA test.”
The test is no longer recommended or even considered safe by most in the medical world, but you wouldn’t have known that from the Today show-and-tell.
Read more »
These days, it’ll cost you anywhere from $10 to $50 to get high off of Oxycontin, depending on the size of the pill and the quality of your hookup. Heroin is cheaper, though, at around $100 a bundle—a grouping of 10 to 13 bags, only one of which is required for a dose. It’s also stronger, longer-lasting and readily available here in Philly, making the switch a no-brainer—economically speaking, anyway—for the hopelessly opiate-addicted looking for a consistent high. Never mind, of course, that that high comes via a more dangerous route of administration from a more dangerous chemical.
This is the train of thought that has driven the rise of heroin usage in Philadelphia, and, indeed, nationally. Prices for either drug, however, aren’t going down anytime soon, and with the economy being the way it is, even junkies might need to start tightening their belts to get by. What stands to replace heroin as the cheap opiate of choice, though, is proving itself hellishly unmanageable. Enter krokodil—and at about a tenth the price, too.
“It’s essentially a cheap alternative to heroin,” says Lieutenant Charles Jackson, a veteran of the Philadelphia narcotics unit of more than 15 years. “It can actually eat your flesh.” Read more »